Logo de la Universdad de Valencia Logo Terapéutica génica y farmacogenómica - TerGenOMIC Logo del portal

Publicaciones del grupo de investigación

 
  • A second update on mapping the human genetic architecture of COVID-19.
  • M Kanai. et al. COVID-19 Host Genetics Initiative.Nature. 2023 Sep;621(7977):E7-E26. doi: 10.1038/s41586-023-06355-3. Epub 2023 Sep 6.PMID: 37674002
  • HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19.
  • Castro-Santos P, et al. Scourge Cohort Group.HLA. 2023 Aug 1. doi: 10.1111/tan.15160. Online ahead of print.PMID: 37528566.
  • Psychiatric polygenic risk as a predictor of COVID-19 risk and severity: insight into the genetic overlap between schizophrenia and COVID-19.
  • Alemany-Navarro M. et al. 2023 Jun 6;13(1):189. doi: 10.1038/s41398-023-02482-7.PMID: 37280221
  • GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
  • Pairo-Castineira E. et al. 2023 May;617(7962):764-768. doi: 10.1038/s41586-023-06034-3. Epub 2023 May 17.PMID: 37198478.
  •  Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain.
  • Agulló L, Muriel J, Margarit C, Escorial M, Garcia D, Herrero MJ, Hervás D, Sandoval J, Peiró AM.J Clin Med. 2023 May 13;12(10):3449. doi: 10.3390/jcm12103449.PMID: 37240556.
  • Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy.
  • Urtasun A, Olivera GG, Sendra L, Aliño SF, Berlanga P, Gargallo P, Hervás D, Balaguer J, Juan-Ribelles A, Andrés MDM, Cañete A, Herrero MJ. Cancers (Basel). 2023 Feb 23;15(5):1424. doi: 10.3390/cancers15051424.PMID: 36900216.
  • Novel genes and sex differences in COVID-19 severity.
  • Cruz R, Diz-de Almeida S. et al. 2022 Nov 10;31(22):3789-3806. doi: 10.1093/hmg/ddac132.PMID: 35708486
  • Study of Oligonucleotides Access and Distribution in Human Peripheral Blood Mononuclear Cells.
  • Fernández-Delgado M, Sendra L, Herrero MJ, Olivera-Pasquini GG, Batista-Duharte A, Aliño SF.Int J Mol Sci. 2022 May 23;23(10):5839. doi: 10.3390/ijms23105839.PMID: 35628649
  • Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder.
  • Trujillo-Del Río C, Tortajada-Pérez J, Gómez-Escribano AP, Casterá F, Peiró C, Millán JM, Herrero MJ, Vázquez-Manrique RP. Mech Ageing Dev. 2022 Mar 30;204:111670. doi: 10.1016/j.mad.2022.111670. Online ahead of print. PMID: 35367225.
  • Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives.
  • Pinto-Merino Á, Labrador J, Zubiaur P, Alcaraz R, Herrero MJ, Montesinos P, Abad-Santos F, Saiz-Rodríguez M. Pharmaceutics. 2022 Mar 3;14(3):559. doi: 10.3390/pharmaceutics14030559. PMID: 35335935.
  • Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up.
  • Sendra L, Olivera GG, López-Andújar R, Serrano C, Rojas LE, Montalvá EM, Herrero MJ, Aliño SF. Pharmaceutics. 2022 Feb 3;14(2):354. doi: 10.3390/pharmaceutics14020354. PMID: 35214086.
  • Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines.
  • García-Alfonso P, Saiz-Rodríguez M, Mondéjar R, Salazar J, Páez D, Borobia AM, Safont MJ, García-García I, Colomer R, García-González X, Herrero MJ, López-Fernández LA, Abad-Santos F. Clin Transl Oncol. 2022 Mar;24(3):483-494. doi: 10.1007/s12094-021-02708-4. Epub 2021 Nov 13. PMID: 34773566.
  • Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study.
  •  Corallo D, Zanon C, Pantile M, Tonini GP, Zin A, Francescato S, Rossi B, Trevisson E, Pinato C, Monferrer E, Noguera R, Aliño SF, Herrero MJ, Biffi A, Viscardi E, Aveic S. Cells. 2021 Oct 9;10(10):2695. doi: 10.3390/cells10102695. PMID: 34685674.
  • Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
  • Olivera GG, Urtasun A, Sendra L, Aliño SF, Yáñez Y, Segura V, Gargallo P, Berlanga P, Castel V, Cañete A, Herrero MJ. Int J Mol Sci. 2021 Sep 10;22(18):9815. doi: 10.3390/ijms22189815. PMID: 34575974.
  • Foxp3 Silencing with Antisense Oligonucleotide Improves Immunogenicity of an Adjuvanted Recombinant Vaccine against Sporothrix schenckii.
  • Batista-Duharte A, Sendra L, Herrero MJ, Portuondo DL, Téllez-Martínez D, Olivera G, Fernández-Delgado M, Javega B, Herrera G, Martínez A, Costa PI, Zeppone Carlos I, Aliño SF. Int J Mol Sci. 2021 Mar 27;22(7):3470. doi: 10.3390/ijms22073470. PMID: 33801683.
  • Multicompartmental Lipopolyplex as Vehicle for Antigens and Genes Delivery in Vaccine Formulations.
  • Sanmartín I, Sendra L, Moret I, Herrero MJ, Aliño SF. Pharmaceutics. 2021 Feb 19;13(2):281. doi: 10.3390/pharmaceutics13020281. PMID: 33669785.
  • Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
  • Megías-Vericat JE, Martínez-Cuadrón D, Herrero MJ, Rodríguez-Veiga R, Solana-Altabella A, Boluda B, Ballesta-López O, Cano I, Acuña-Cruz E, Cervera J, Poveda JL, Sanz MÁ, Aliño SF, Montesinos P. Pharmacogenet Genomics. 2021 Mar 5. doi: 10.1097/FPC.0000000000000431. Online ahead of print. PMID: 33675324
  • Mitochondrial DNA Replacement Techniques to Prevent Human Mitochondrial Diseases.
  • Sendra L, García-Mares A, Herrero MJ, Aliño SF. Int J Mol Sci. 2021 Jan 7;22(2):551. doi: 10.3390/ijms22020551. PMID: 33430493.
  • Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
  • Juan Eduardo Megías-Vericat , David Martínez-Cuadrón , María José Herrero , Rebeca Rodríguez-Veiga , Antonio Solana-Altabella , Blanca Boluda , Octavio Ballesta-López , Isabel Cano , Evelyn Acuña-Cruz , José Cervera , José Luis Poveda , MiguelÁngel Sanz , Salvador F Aliño, Pau Montesinos  Affiliations expand, PMID: 33135528, DOI: 10.1080/10428194.2020.1839650.
  • Gold Nanoparticle-Assisted Virus Formation by Means of the Delivery of an Oncolytic Adenovirus Genome.
  • Luis Sendra, Antonio Miguel, M. Carmen Navarro-Plaza, María José Herrero*, José de la Higuera, Consuelo Cháfer-Pericás, Elena Aznar , M. Dolores Marcos, Ramón Martínez-Máñez , Luis Alfonso Rojas, Ramón Alemany and Salvador F. Aliño Nanomaterials 2020, 10(6), 1183; https://doi.org/10.3390/nano10061183 - 17 Jun 2020.
  • An Pediatr (Barc)
  • 2020 Apr 14;S1695-4033(20)30096-5. doi: 10.1016/j.anpedi.2020.02.015. Online ahead of print. [Cancer in the First 18 Months of Life] [Article in Spanish] Andrea Urtasun Erburu 1, Maria José Herrero Cervera 2, Adela Cañete Nieto 3 Affiliations expand PMID: 32303474 DOI: 10.1016/j.anpedi.2020.02.015.
  • MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients.
  • Olivera GG, Yáñez Y, Gargallo P, Sendra L, Aliño SF, Segura V, Sanz MÁ, Cañete A, Castel V, Font De Mora J, Hervás D, Berlanga P and Herrero MJ. Int J Mol Sci. 2020 Apr 14;21(8):2714. doi: 10.3390/ijms21082714. PMID: 32295184 Free PMC article.
  • Progress in the Use of Antisense Oligonucleotides for Vaccine Improvement.
  • Batista-Duharte A, Sendra L, Herrero MJ, Téllez-Martínez D, Carlos IZ, Aliño SF. Biomolecules. 2020 Feb 17;10(2):316. doi: 10.3390/biom10020316. PMID: 32079263.
  • CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy.
  • Genvigir FDV, Campos-Salazar AB, Felipe CR, Tedesco-Silva H Jr, Medina-Pestana JO, Doi SQ, Cerda A, Hirata MH, Herrero MJ, Aliño SF, Hirata RDC. Pharmacogenomics. 2020 Jan;21(1):7-21. doi: 10.2217/pgs-2019-0120. PMID: 31849280.
  • Efficacy of interleukin 10 gene hydrofection in pig liver vascular isolated 'in vivo' by surgical procedure with interest in liver transplantation.
  • Sendra L, Herrero MJ, Montalvá EM, Noguera I, Orbis F, Díaz A, Fernández-Delgado R, López-Andújar R, Aliño SF. PLoS One. 2019 Nov 5;14(11):e0224568. doi: 10.1371/journal.pone.0224568. eCollection 2019. PMID: 31689315.
  • Effect of hIL10 NAked DNA Delivery on Swine Heart Tissue after Acute Infarct.
  • Luis Sendra, MJ Herrero*, Gladys Olivera, Ana Díaz, Inmma Noguera, Amparo Ruiz-Saurí, Rafael Fernández-Delgado, Vicent Bodí, Salvador F. Aliño. Arch Clin Med Case Rep 2019; 3(4):183-189. DOI: 10.26502/acmcr.96550079. 15 August 2019.
  • Colorectal cancer: pharmacogenetics support to choose the right drug prescription.
  • Gladys Olivera, Luis Sendra, María José Herrero*,Carlos Puig, Salvador F. Aliño. Pharmacogenomics. Review. 1 August 2019.10.2217/pgs-2019-0041.
  • Pharmacogenetics implementation in the clinics: information and guidelines for germline variants.
  • Gladys Olivera, Luis Sendra, María José Herrero*, Pablo Berlanga, Pablo Gargallo, Yania Yáñez, Andrea Urtasun, Jaime Font de Mora, Victoria Castel, Adela Cañete, Salvador F. Aliño. Cancer Drug Resistance (Open Access). DOI: 10.20517/cdr.2018.25.Review. 28Feb2019.
  • Personalized medicine into health national services: barriers and potentialities.
  • Ana E. Rodríguez Vicente, María José Herrero Cervera, María Luisa Bernal, Luis Rojas, Ana M. Peiró (all autors contributed equally). Drug Metabol Pers Ther, aop 2018. https://doi.org/10.1515/dmpt-2018-0017 Received June 21, 2018; accepted October 3, 2018.
  • Traslational advances of hydrofection by hydrodynamic injection.
  • Sendra L, Herrero Mj, Aliño SF. GENES (Basel)  2018 Mar 1; 9 (3): pii:E136.  doi: 10.3390/genes9030136. Review. PMID:29494564.
  • Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia.
  • Megias-Vericat JE, Martinez-Cuadron D, Herrero MJ, Alino SF, Poveda JL, Sanz MA, Montesinos P. Curr Drug Metab. 2018;19(1):55-74. doi: 10.2174/1389200218666171101124931. Review. PMID: 29090664
  • Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment.
  • Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Martínez-Cuadrón D, Rojas L, Rodríguez-Veiga R, Boluda B, Sendra L, Cervera J, Poveda JL, Sanz MÁ, Aliño SF. Leuk Lymphoma. 2017 Jun 2:1-15. doi: 10.1080/10428194.2017.1323267. [Epub ahead of print] PMID: 28573946. 2017 Dec;58(12):2880-2894. doi: 10.1080/10428194.2017.1323267. Epub 2017 Jun 2.
  • Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia.
  • Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF. Pharmacogenet Genomics. 2017 Jul;27(7):270-274. doi: 10.1097/FPC.0000000000000286. PMID: 28570300
  • Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders. Editors: Brunetti-Pierri, Nicola (Ed.). Chapter: Physical Methods of Gene Delivery. Herrero MJ, Sendra L, Miguel A, Aliño SF. Pages113-135. ISBN 978-3-319-53457-2. DOI 10.1007/978-3-319-53457-2. Springer 2017.
  • Hydrodynamic IL10 gene transfer in human colon: a possible new strategy for treatment of Crohn's disease. Results from an "ex-vivo" study.
  • Inflammatory Bowel Diseases. Frasson M, Sendra L, Miguel A, Herrero MJ, Montalvá E, López-Andújar R, Martínez-Pastor J, Martí-Bonmatí L, Granero EG, Aliño S. Inflamm Bowel Dis. 2017 Aug;23(8):1360-1370. doi: 10.1097/MIB.0000000000001197. PMID: 28708803
  • Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma.
  • Miguel A1, Sendra L1, Noé V2, Ciudad CJ2, Dasí F3, Hervas D4, Herrero MJ5, Aliño SF6. Onco Targets Ther. 2017 Jan 23;10:503-514. doi: 10.2147/OTT.S104393. eCollection 2017.
  • Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy.
  • Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Rojas L, Martínez-Cuadrón D, Rodríguez-Veiga R, Sendra L, Cervera J, Poveda JL, Sanz MÁ, Aliño SF. Pharmacogenomics J. 2017 May 9. doi: 10.1038/tpj.2017.19. [Epub ahead of print] PMID: 28485375.
  • Efficacy of hydrodynamic IL10 gene transfer in human liver segments with interest in transplantation.
  • Sendra Gisbert L, Miguel Matas A, Sabater Ortí L, Herrero Cervera MJ, Sabater Olivas L, Montalvá Orón EM, Frasson M, Abargues López R, López-Andújar R, García-Granero Ximénez E, Aliño Pellicer SF. Liver Transpl. 2016 Oct 26. doi: 10.1002/lt.24667. [Epub ahead of print] PMID:27783460.
  • Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
  • Megías-Vericat JE, Montesinos P, Herrero MJ, Moscardó F, Bosó V, Rojas L, Martínez-Cuadrón D, Hervás D, Boluda B, García-Robles A, Rodríguez-Veiga R, Martín-Cerezuela M, Cervera J, Sendra L, Sanz J, Miguel A, Lorenzo I, Poveda JL, Sanz MÁ, Aliño SF. Leuk Lymphoma. 2016 Oct 4:1-10. Leuk and Lymphoma, Issue 5, Vol.58, 2017 PMID: 27701910.
  • Studying Closed Hydrodynamic Models of "In Vivo" DNA Perfusion in Pig Liver for Gene Therapy Translation to Humans.
  • Sendra L, Miguel A, Pérez-Enguix D, Herrero MJ, Montalvá E, García-Gimeno MA, Noguera I, Díaz A, Pérez J, Sanz P, López-Andújar R, Martí-Bonmatí L, Aliño SF. PLoS One. 2016 Oct 3;11(10):e0163898. doi: 10.1371/journal.pone.0163898. PMID: 27695064
  • Pharmacogenomics and the treatment of acute myeloid leukemia.
  • Megías-Vericat JE, Montesinos P, Herrero MJ, Bosó V, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF. Pharmacogenomics. 2016 Jul; 17(11):1245-1272. PMID: 27381050.
  • Clinical implementation of pharmacogenetics.
  • García-González X#, Cabaleiro T#, Herrero MJ#, McLeod H, López-Fernández LA. Drug Metabol Personal Ther. 2016 Mar 1;31(1):9-16. doi: 10.1515/dmpt-2015-0031. PMID: 26751902.
  • A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia.
  • Megías-Vericat JE*, Herrero MJ*, Rojas L, Montesinos P, Bosó V, Moscardó F, Martínez-Cuadrón D, Poveda JL, Sanz MÁ, Aliño SF. Pharmacogenomics J. 2016 Feb;16(1):30-40. doi: 10.1038/tpj.2015.80. Epub 2015 Dec 8.PMID: 26644203.
  • Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis.
  • Megías-Vericat JE*, Rojas L, Herrero MJ*, Bosó V, Montesinos P, Moscardó F, Poveda JL, Sanz MA, Aliño SF. Pharmacogenomics J. 2016 Feb;16(1):1-2. doi: 10.1038/tpj.2015.79. Epub 2015 Oct 27. No abstract available. (LETTER) PMID: 26503809
  • Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung
  • Transplantation.  Ruiz J, Herrero MJ, Bosó V, Megías JE, Hervás D, Poveda JL, Escrivá J, Pastor A, Solé A, Aliño SF. Int J Mol Sci. 2015 Aug 25; 16(9):20168-82. doi: 10.3390/ijms160920168. IF: 2.86, Q2 PMID: 26307985.
  • Association of Single Nucleotide Polymorphisms to the efficacy and safety of immunosuppressant therapy after heart transplantation
  • Ignacio Sánchez-Lázaro, María José Herrero*, Consuelo Jordán-De Luna, Virginia Bosó, Luis Almenar, Luis Rojas, Luis Martínez-Dolz, Juan Eduardo Megías-Vericat, Luis Sendra, Antonio Miguel, José Luis Poveda, Salvador F. Aliño Pharmacogenomics. 2015 Jun;16(9):971-9.Q2. PMID: 26107754.
  • Human AAT gene transfer to pig liver improve by using a perfusion isolated organ endovascular procedure.
  • Luis Sendra, Daniel Pérez, Antonio Miguel, María José Herrero*, Inmaculada Noguera, Ana Díaz, Domingo Barettino, Luis Martí-Bonmatí, Salvador F. Aliño. European Radiology, 2015 Apr 25. [Epub ahead of print]. European Radiology: Volume 26, Issue 1 (2016), Page 95-102.
  • Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies.
  • Megías-Vericat JE, Rojas L, Herrero MJ, Bosó V, Montesinos P, Moscardó F, Poveda JL, Sanz MÁ, Aliño SF. Pharmacogenomics J. 2015 Apr;15(2):109-18. doi: 10.1038/tpj.2014.80. Epub 2015 Jan 6. Review Q1. PMID: 25558979.
  • Low RNA translation activit limits the efficacy of hydrodynamic gene transfer to pig liver in vivo.
  • Sendra L, Carreño O, Miguel A, Montalvá E, Herrero MJ*, Orbis F, Noguera I, Barettino D, López-Andújar R, Aliño SF*. J Gene Med. 2014 Jul;16(7-8):179-92. doi: 10.1002/jgm.2777. PMID: 25092576
  • Single nucleotide polymorphisms and taxane toxicity in breast cancer patients. Bosó V; Herrero MJ; Santaballa A, Palomar L; Megias JE; de la Cueva H; Rojas L; Marqués MR, Poveda JL, Montalar J; Aliño SF. Pharmacogenomics, 2014; Nov;15(15):1845-58. PMID: 25495407
  • Human Interleukin-10 Naked DNA Delivery to Infarcted Pig Heart by Catheter Mediated Retrograde Injection in Coronary Sinus Luis Sendra, Antonio Miguel, María Jose Herrero*, Maria Jose Forteza, Fabian L. Chaustre, Inmaculada Noguera, Ana Diaz, Vicent Bodi, and Salvador F Alino. J Clinical and Experimental Cardiology  2014, 5:6
  • Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: A systematic review and meta-analysis of observational studies. Luis Rojas, Ignacio Neumann, María José Herrero*, Virginia Bosó, Jorge Reig, José Luis Poveda, Sergio Bea, Juan Megías, and Salvador F Aliño. Pharmacogenomics J. 2015 Feb;15(1):38-48. doi: 10.1038/tpj.2014.38. Epub 2014 Sep 9. PMID: 25201288.
  • Antitumor Cell-Complex Vaccines Employing Genetically Modified Tumor Cells and Fibroblasts. 
  • Miguel A, Herrero MJ*, Sendra L, Botella R, Diaz A, Algás R, Aliño SF. Toxins. 2014; 6(2):636-649. FI: 2.13.
  • Pharmacogenetics of Tacrolimus in solid organ transplantation: one more approach to manage its effectiveness and safety.
  • MJ Herrero, V Bosó, J Ruiz, L Rojas, S Bea, J Sánchez-Plumed, J Hernández, JL Poveda, SF Aliño. Capítulo en libro “Tacrolimus: effectiveness, safety and drug interactions”. Editor D Raptis. Nova Biomedical, Nova Sciene Publishers Inc NewYork. ISBN: 978-1-62808-370-5 (eBook). 2013
  • A Surgical Model for Isolating the Pig Liver in vivo for Gene Therapy.
  • Carreño O, Sendra L, Montalvá E, Miguel A, Orbis F, Herrero MJ, Noguera I, Aliño SF, Lopez-Andujar R. Eur Surg Res. 2013 Sep 10;51(1-2):47-57. [Epub ahead of print] PMID: 24022646. FI: 0.75
  • Comparative antitumor effect among GM-CSF, IL-12 and GM-CSF+IL-12 genetically modified tumor cell vaccines.
  • Miguel A, Herrero MJ*, Sendra L, Botella R, Algás R, Sánchez M, Aliño SF. Cancer Gene Ther. 2013 Aug 23. doi: 10.1038/cgt.2013.54. [Epub ahead of print] PMID: 23969885. Cancer Gene Ther. 2013 Oct;20(10):576-81. doi: 10.1038/cgt.2013.54. Epub 2013 Aug 23. FI: 2.95
  • Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.
  • Rojas LE, Herrero MJ, Bosó V, García-Eliz M, Poveda JL, Librero J, Aliño SF. Pharmacogenet Genomics. 2013 Oct;23(10):509-517. FI: 3.61 PMID: 23873120.
  • Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population.
  • Virginia Bosó, María J. Herrero, Enrique Buso, Juan Galán, Luis Almenar, Ignacio Sánchez-Lázaro, Jaime Sánchez-Plumed, Sergio Bea, Martín Prieto, María García, Amparo Pastor, Amparo Sole, José Luis Poveda, Salvador F. Aliño. Ther Drug Monit. 2013 Nov 13. [Epub ahead of print] PMID: 24232128. Ther Drug Monit. 2014 Apr;36(2):159-68. doi: 10.1097/FTD.0b013e3182a94e65. FI: 2.23 PMID: 24232128
  • Increased Hospital Stay and Allograft Disfunction in Renal Transplanted Patients with CYP2C19 AA Variant in SNP RS4244285.
  • Boso V, Herrero MJ, Bea S, Galiana M, Marrero P, Marques MR, Hernandez J, Sanchez-Plumed J, Poveda JL, Alino SF. Drug Metab Dispos. Epub:2012 Nov 21. PMID:23175667. 2013 Feb;41(2):480-7. FI: 3.36
  • Practical Pharmacogenetics and Single Nucleotide Polymorphisms (SNPs) in Renal Transplantation.
  • María José Herrero, Virginia Bosó, Luis Rojas, Sergio Bea, Jaime Sánchez Plumed, Julio Hernández, Jose Luis Poveda and Salvador F. Aliño .Book: Current Issues and Future Direction in Kidney Transplantation. Febrero 2013. ISBN 978-953-51-0985-3, edited by Thomas Rath. Ed. InTech.